Skip to main content
. Author manuscript; available in PMC: 2014 Apr 9.
Published in final edited form as: Int J Tuberc Lung Dis. 2013 Feb 7;17(4):486–492. doi: 10.5588/ijtld.12.0133

Table 7.

Drug intolerance/allergy

Intolerance/
allergy
All patients
(n = 506)
Cases: persons who took
>12 months to complete treatment
(n = 253)
Controls: persons who took
<12 months to complete treatment
(n = 253)



INH R PZA Any drug INH R PZA Any drug INH R PZA Any drug
Fever/chills 4 4 2 10 4 2 6
Gl upset 2 10 9 21 2 2 7 11 2 2
Pruritus/rash 8 4 12 6 4 10 2 1 3
Neurologic 4 1 5 2 2 2 1 3
Arthralgias 5 5 3 3 2 2
Flushing 2 2 2 2
Cytopenias 9 9 9 9
Renal failure 2 2 1 1 1 1
Pregnancy 3 3 1 1 2 2
Anaphylaxis 1 3 1 5 1 3 1 5
Any, n (%) 18 (3.6) 35 (6.9) 35 (6.9) 51 (12.1) 13 (5.1) 33 (13.0) 23 (9.1) 44 (17.4) 5 (2.0) 2 (0.8) 12 (4.7) 7 (2.8)
*

Seven patients were intolerant to both INH and PZA; 5 patients were intolerant to both INH and RMP.

INH = isoniazid; R = rifamycin; PZA = pyrazinamide; GI = gastrointestinal.